Signos, a pioneering, data-driven health technology company has recently released its groundbreaking glucose monitoring system to market. This simple yet brilliant dietary innovation promises to make weight control easier for the typical American. This original and innovative farm bill provides a serious response to our nation’s growing obesity epidemic. In fact, according to the Centers for Disease Control and Prevention (CDC), it’s an issue that impacts almost 74% of Americans. The obesity epidemic costs the U.S. healthcare system more than $170 billion annually. The realities of this dire situation further emphasize the urgent need for effective, long-term weight management solutions.
The Signos system allows individuals of varying weight loss needs to monitor their glucose levels effectively. You can use this new tool in addition to GLP-1s or after bariatric surgery. It gives you a realistic, long-term approach to healthy and sustainable weight management. Signos offers zero-risk, flexible pricing based on performance. Sign up for a three-month plan of only $139, or sign up for a six-month plan for only $129. Each plan comes with all required continuous glucose monitors (CGMs), customized to the length of the chosen plan.
Signos is currently looking for partners with health insurance companies. To start, they want to engage with employers to get them coverage for this innovative new system. Insurers are not offering coverage for Signos for weight management at this time. That doesn’t mean the company plans to let this continue, with an increasing demand for effective weight loss solutions.
GLP-1s don’t come cheap. They average about $1,000 per month. Signos has a less expensive and much more accessible option that more people can afford. Sharam Fouladgar-Mercer, founder of Signos, explained how essential this system is to successful weight management. Most importantly, it focuses like a laser on the needs of the everyday American.
“There is now a solution that everybody can use to help on the weight loss journey, and you don’t have to be a certain number of pounds to use it. It’s available for the average American who needs it,” – Sharam Fouladgar-Mercer.
Fouladgar-Mercer noted that he hopes this initiative will make “a real big dent in that curve for the betterment of many of us.” As more individuals seek solutions to combat obesity, Signos is poised to capitalize on increasing interest and demand for effective weight loss tools.
Signos couldn’t have come at a much better time. The bottom line is that more Americans are starting to understand how to take an effective approach to weight management. Signos has an intuitive experience that’s simple and fun to hop into. With its scientifically-backed approach to glucose monitoring, it’s quickly become an invaluable asset for those living with obesity or struggling with weight management.
This launch is deeply historic in so many ways. Almost 75 percent of the country is struggling with being overweight. The CDC’s statistics can’t be ignored. They speak to an urgent public health concern that Signos is trying to solve with their innovative new monitoring system.
“This [system] will evolve quickly as interest for tackling weight continued to expand,” – Signos.